Table 1.

Baseline carotid artery intima-media thickness and demographic, clinical and laboratory characteristics.

Variable	Evaluable Allicor Recipients (n=93)	Evaluable Placebo Recipients (n=103)
Carotid intima-media thickness, mm	0.929±0.015	0.937±0.015
Age, years	60,4±1,1	61,5±0,8
Smoking history, n (%)	30 (32.3)	32 (31.1)
Family history, n (%)	18 (19.4)	17 (16.5)
Systolic blood pressure, mm Hg	133.3±1.3	131.9±1.4
Diastolic blood pressure, mm Hg	81.8±0.8	81.2±0.9
Total cholesterol, mMol/L	6.14±0.12	6.02±0.10
Triglycerides, mMol/L	2.17±0.14	2.23±0.12
HDL cholesterol, mMol/L	1.07±0.03	1.10±0.03
LDL cholesterol, mMol/L	4.06±0.10	3.88±0.09
Serum-induced intracellular cholesterol accumulation (serum atherogenicity *), % of control	156.2±5.1	156.4±5.2

^*Serum atherogenicity was determined as described in “Subjects and Methods” section. Total intracellular cholesterol content of control cells cultured without patient’s serum addition was set for 100%. The cholesterol content of cells cultured in the presence of patient’s serum was expressed in % of control cells. The serum that induced statistically significant increase in intracellular cholesterol content as compared to control cells was defined as atherogenic.